Clinical Trial Update: The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and efficacy of phentolamine mesylate ophthalmic solution for severe night vision disturbances has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Night Blindness
• Night Vision Disturbances

Drugs mentioned

• Phentolamine Mesylate Ophthalmic Solution (phentolamine mesylate)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Night Vision Complaints, Decrease in Night Vision | Phase 2 | Status: COMPLETED